CLINICAL TRIALS PROFILE FOR BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN
✉ Email this page to a colleague
All Clinical Trials for BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00471952 ↗ | Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2007-04-01 | The purpose of this study is to evaluate the effect of rizatriptan, alone or combined with caffeine for treating acute attacks of migraine. Each subject will have 3 months to treat 3 acute migraine headache attacks. Each subject will be dispensed one box containing 3 packets of study medication labeled for Headache #1, Headache #2, or Headache #3. Each packet wil contain either Maxalt 10mg MLT or a Maxalt placebo (sugar pill), and a capsule containing either caffeine 75mg or a capsule containing placebo (sugar). One headache will be treated with a combination of Maxalt 10mg MLT and caffeine. Another headache will be treated with a combination of Maxalt 10mg MLT and a capsule containing placebo. A third headache will be treated with just placebo. Neither the subject, the study coordinator, or your study doctor will know in which order you will receive the three different treatments. This information is available in case of emergency. |
| NCT00471952 ↗ | Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache | Completed | Diamond Headache Clinic | Phase 3 | 2007-04-01 | The purpose of this study is to evaluate the effect of rizatriptan, alone or combined with caffeine for treating acute attacks of migraine. Each subject will have 3 months to treat 3 acute migraine headache attacks. Each subject will be dispensed one box containing 3 packets of study medication labeled for Headache #1, Headache #2, or Headache #3. Each packet wil contain either Maxalt 10mg MLT or a Maxalt placebo (sugar pill), and a capsule containing either caffeine 75mg or a capsule containing placebo (sugar). One headache will be treated with a combination of Maxalt 10mg MLT and caffeine. Another headache will be treated with a combination of Maxalt 10mg MLT and a capsule containing placebo. A third headache will be treated with just placebo. Neither the subject, the study coordinator, or your study doctor will know in which order you will receive the three different treatments. This information is available in case of emergency. |
| NCT00799045 ↗ | Clopidogrel For the Prevention of New Onset Migraine Headache Following Transcatheter Closure of Atrial Septal Defects | Completed | Bristol-Myers Squibb | Phase 4 | 2008-10-01 | The addition of clopidogrel on top of aspirin may reduce the occurrence of new-onset migraine headache episodes following transcatheter ASD closure. |
| NCT00799045 ↗ | Clopidogrel For the Prevention of New Onset Migraine Headache Following Transcatheter Closure of Atrial Septal Defects | Completed | Sanofi | Phase 4 | 2008-10-01 | The addition of clopidogrel on top of aspirin may reduce the occurrence of new-onset migraine headache episodes following transcatheter ASD closure. |
| NCT00799045 ↗ | Clopidogrel For the Prevention of New Onset Migraine Headache Following Transcatheter Closure of Atrial Septal Defects | Completed | Laval University | Phase 4 | 2008-10-01 | The addition of clopidogrel on top of aspirin may reduce the occurrence of new-onset migraine headache episodes following transcatheter ASD closure. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN
Condition Name
Clinical Trial Locations for BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN
Trials by Country
Clinical Trial Progress for BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN
Clinical Trial Phase
Clinical Trial Sponsors for BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN
Sponsor Name
